

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.60555204 |
| 2 | exocrine pancreas development (GO:0031017) | 4.72571508 |
| 3 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.56613129 |
| 4 | protein complex biogenesis (GO:0070271) | 4.43764914 |
| 5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.38863278 |
| 6 | oxidative phosphorylation (GO:0006119) | 4.37102514 |
| 7 | protein retention in ER lumen (GO:0006621) | 4.36567743 |
| 8 | proteasome assembly (GO:0043248) | 4.25873129 |
| 9 | amino acid salvage (GO:0043102) | 4.18264479 |
| 10 | L-methionine salvage (GO:0071267) | 4.18264479 |
| 11 | L-methionine biosynthetic process (GO:0071265) | 4.18264479 |
| 12 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.16774217 |
| 13 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.03399086 |
| 14 | ATP synthesis coupled proton transport (GO:0015986) | 4.03399086 |
| 15 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.01457469 |
| 16 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.99274768 |
| 17 | proline biosynthetic process (GO:0006561) | 3.98924317 |
| 18 | formation of translation preinitiation complex (GO:0001731) | 3.96728338 |
| 19 | cotranslational protein targeting to membrane (GO:0006613) | 3.96400309 |
| 20 | protein targeting to ER (GO:0045047) | 3.95050356 |
| 21 | branched-chain amino acid catabolic process (GO:0009083) | 3.94650719 |
| 22 | GDP-mannose metabolic process (GO:0019673) | 3.92656323 |
| 23 | intestinal cholesterol absorption (GO:0030299) | 3.91102930 |
| 24 | protein localization to endoplasmic reticulum (GO:0070972) | 3.82780950 |
| 25 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.77295094 |
| 26 | viral transcription (GO:0019083) | 3.76999337 |
| 27 | ribosomal small subunit assembly (GO:0000028) | 3.74119718 |
| 28 | maturation of SSU-rRNA (GO:0030490) | 3.73426484 |
| 29 | valine metabolic process (GO:0006573) | 3.69799887 |
| 30 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.69107400 |
| 31 | translational termination (GO:0006415) | 3.68857125 |
| 32 | proline metabolic process (GO:0006560) | 3.68048031 |
| 33 | cytochrome complex assembly (GO:0017004) | 3.63794026 |
| 34 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.60103482 |
| 35 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.56115768 |
| 36 | mannosylation (GO:0097502) | 3.55293056 |
| 37 | translation (GO:0006412) | 3.55132071 |
| 38 | sulfur amino acid biosynthetic process (GO:0000097) | 3.51670453 |
| 39 | branched-chain amino acid metabolic process (GO:0009081) | 3.51602129 |
| 40 | base-excision repair, AP site formation (GO:0006285) | 3.49822620 |
| 41 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.47666907 |
| 42 | termination of RNA polymerase III transcription (GO:0006386) | 3.47666907 |
| 43 | translational elongation (GO:0006414) | 3.47460075 |
| 44 | galactose catabolic process (GO:0019388) | 3.43382762 |
| 45 | response to interferon-beta (GO:0035456) | 3.39036923 |
| 46 | respiratory chain complex IV assembly (GO:0008535) | 3.37941959 |
| 47 | respiratory electron transport chain (GO:0022904) | 3.37628487 |
| 48 | NADH metabolic process (GO:0006734) | 3.34995458 |
| 49 | deoxyribonucleotide catabolic process (GO:0009264) | 3.33773355 |
| 50 | regulation of mitochondrial translation (GO:0070129) | 3.32717453 |
| 51 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.32547216 |
| 52 | ribosomal small subunit biogenesis (GO:0042274) | 3.31404198 |
| 53 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.31202611 |
| 54 | cysteine metabolic process (GO:0006534) | 3.28793909 |
| 55 | electron transport chain (GO:0022900) | 3.28764349 |
| 56 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.22220663 |
| 57 | serine family amino acid biosynthetic process (GO:0009070) | 3.21756989 |
| 58 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.21492207 |
| 59 | translational initiation (GO:0006413) | 3.20147676 |
| 60 | deoxyribose phosphate catabolic process (GO:0046386) | 3.19047734 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.18720948 |
| 62 | mitochondrial calcium ion transport (GO:0006851) | 3.17072883 |
| 63 | methionine biosynthetic process (GO:0009086) | 3.16815839 |
| 64 | digestion (GO:0007586) | 3.16619581 |
| 65 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.14859327 |
| 66 | aspartate family amino acid biosynthetic process (GO:0009067) | 3.14351664 |
| 67 | negative regulation of B cell apoptotic process (GO:0002903) | 3.11354185 |
| 68 | quinone biosynthetic process (GO:1901663) | 3.10242482 |
| 69 | ubiquinone biosynthetic process (GO:0006744) | 3.10242482 |
| 70 | cellular response to interferon-beta (GO:0035458) | 3.07563436 |
| 71 | peptidyl-histidine modification (GO:0018202) | 3.06641483 |
| 72 | Golgi transport vesicle coating (GO:0048200) | 3.06240114 |
| 73 | COPI coating of Golgi vesicle (GO:0048205) | 3.06240114 |
| 74 | autophagic vacuole fusion (GO:0000046) | 3.05866397 |
| 75 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.03044381 |
| 76 | negative regulation of ligase activity (GO:0051352) | 3.03044381 |
| 77 | cytidine deamination (GO:0009972) | 3.02757290 |
| 78 | cytidine metabolic process (GO:0046087) | 3.02757290 |
| 79 | cytidine catabolic process (GO:0006216) | 3.02757290 |
| 80 | transcytosis (GO:0045056) | 3.02199114 |
| 81 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.01714437 |
| 82 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.01510619 |
| 83 | metallo-sulfur cluster assembly (GO:0031163) | 3.01381160 |
| 84 | iron-sulfur cluster assembly (GO:0016226) | 3.01381160 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.98763169 |
| 86 | ribosomal large subunit biogenesis (GO:0042273) | 2.98361136 |
| 87 | L-serine metabolic process (GO:0006563) | 2.98118687 |
| 88 | nucleobase biosynthetic process (GO:0046112) | 2.96842758 |
| 89 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.96223075 |
| 90 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.96223075 |
| 91 | NADH dehydrogenase complex assembly (GO:0010257) | 2.96223075 |
| 92 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.95932126 |
| 93 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.95932126 |
| 94 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.95932126 |
| 95 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.95752129 |
| 96 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.95752129 |
| 97 | rRNA modification (GO:0000154) | 2.95582615 |
| 98 | GTP biosynthetic process (GO:0006183) | 2.95196241 |
| 99 | signal peptide processing (GO:0006465) | 2.93610415 |
| 100 | heme biosynthetic process (GO:0006783) | 2.93515497 |
| 101 | glycine metabolic process (GO:0006544) | 2.92225221 |
| 102 | purine nucleobase biosynthetic process (GO:0009113) | 2.91977776 |
| 103 | aspartate family amino acid catabolic process (GO:0009068) | 2.90259961 |
| 104 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.89404037 |
| 105 | viral life cycle (GO:0019058) | 2.89014567 |
| 106 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.88103766 |
| 107 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.88103766 |
| 108 | cobalamin metabolic process (GO:0009235) | 2.88032671 |
| 109 | methionine metabolic process (GO:0006555) | 2.87856409 |
| 110 | protein-cofactor linkage (GO:0018065) | 2.86906102 |
| 111 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.85201726 |
| 112 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.85201726 |
| 113 | aspartate family amino acid metabolic process (GO:0009066) | 2.85168698 |
| 114 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.83901059 |
| 115 | L-phenylalanine metabolic process (GO:0006558) | 2.83901059 |
| 116 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.82049776 |
| 117 | cellular protein complex disassembly (GO:0043624) | 2.81624477 |
| 118 | 4-hydroxyproline metabolic process (GO:0019471) | 2.81316535 |
| 119 | folic acid metabolic process (GO:0046655) | 2.80131329 |
| 120 | regulation of translation in response to stress (GO:0043555) | 2.80051071 |
| 121 | chaperone-mediated protein transport (GO:0072321) | 2.77335572 |
| 122 | C-terminal protein lipidation (GO:0006501) | 2.75960901 |
| 123 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.73814771 |
| 124 | ubiquinone metabolic process (GO:0006743) | 2.72758177 |
| 125 | immunoglobulin mediated immune response (GO:0016064) | 2.72341637 |
| 126 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.68858196 |
| 127 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.67846852 |
| 128 | organelle membrane fusion (GO:0090174) | 2.67028572 |
| 129 | positive regulation of prostaglandin secretion (GO:0032308) | 2.66548280 |
| 130 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.66508655 |
| 131 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.63526223 |
| 132 | regulation of B cell apoptotic process (GO:0002902) | 2.63479883 |
| 133 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.61873740 |
| 134 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.61852098 |
| 135 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.61795291 |
| 136 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.58317567 |
| 137 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.56694235 |
| 138 | pentose metabolic process (GO:0019321) | 2.55648533 |
| 139 | rRNA methylation (GO:0031167) | 2.54220480 |
| 140 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.53993817 |
| 141 | NIK/NF-kappaB signaling (GO:0038061) | 2.52907991 |
| 142 | positive regulation of protein homooligomerization (GO:0032464) | 2.51984250 |
| 143 | GPI anchor biosynthetic process (GO:0006506) | 2.51750512 |
| 144 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.50954684 |
| 145 | UTP biosynthetic process (GO:0006228) | 2.50394694 |
| 146 | nucleotide salvage (GO:0043173) | 2.48786032 |
| 147 | pseudouridine synthesis (GO:0001522) | 2.48071298 |
| 148 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.47970606 |
| 149 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.46772843 |
| 150 | ATP biosynthetic process (GO:0006754) | 2.46671670 |
| 151 | protein targeting to mitochondrion (GO:0006626) | 2.45692620 |
| 152 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.44554736 |
| 153 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.44381894 |
| 154 | UV protection (GO:0009650) | 2.41674091 |
| 155 | viral protein processing (GO:0019082) | 2.41085878 |
| 156 | establishment of protein localization to mitochondrion (GO:0072655) | 2.39959257 |
| 157 | hydrogen ion transmembrane transport (GO:1902600) | 2.38870812 |
| 158 | regulation of defense response to virus by host (GO:0050691) | 2.36819495 |
| 159 | deoxyribose phosphate metabolic process (GO:0019692) | 2.36810493 |
| 160 | positive regulation of defense response to virus by host (GO:0002230) | 2.36513805 |
| 161 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.36087388 |
| 162 | regulation of autophagic vacuole assembly (GO:2000785) | 2.34969146 |
| 163 | tRNA modification (GO:0006400) | 2.34426240 |
| 164 | virion assembly (GO:0019068) | 2.34109615 |
| 165 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.33450051 |
| 166 | mature B cell differentiation involved in immune response (GO:0002313) | 2.33019774 |
| 167 | response to misfolded protein (GO:0051788) | 2.32690369 |
| 168 | platelet dense granule organization (GO:0060155) | 2.31315025 |
| 169 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.31114315 |
| 170 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.30986200 |
| 171 | positive regulation of T cell apoptotic process (GO:0070234) | 2.29866628 |
| 172 | protein insertion into membrane (GO:0051205) | 2.29686199 |
| 173 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.27977547 |
| 174 | negative regulation of telomere maintenance (GO:0032205) | 2.27613896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.91717965 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.65462586 |
| 3 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.49074164 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.42224274 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.38339388 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.34339629 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.29194548 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.07786298 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.96153063 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.90911463 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.74788727 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.62436885 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.47317220 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.46171162 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.45542933 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.41056559 |
| 17 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.27722845 |
| 18 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.23626396 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.22482498 |
| 20 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.17711807 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.17254931 |
| 22 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.16638732 |
| 23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.14694794 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.11832309 |
| 25 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.08314088 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.06379912 |
| 27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.04817612 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.99900771 |
| 29 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.99817830 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.99428549 |
| 31 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.98715645 |
| 32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.98579104 |
| 33 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.96506367 |
| 34 | P68_20966046_ChIP-Seq_HELA_Human | 1.91443764 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88802929 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.87372733 |
| 37 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.87016809 |
| 38 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.83371478 |
| 39 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.83146774 |
| 40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82070775 |
| 41 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.81737584 |
| 42 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.75943553 |
| 43 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.75664198 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.72071218 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.69812664 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.67305083 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66810381 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.65425994 |
| 49 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.63609467 |
| 50 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.60177466 |
| 51 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.57532324 |
| 52 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.53769066 |
| 53 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.52171425 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51598675 |
| 55 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50698401 |
| 56 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.50458181 |
| 57 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.50164668 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48622703 |
| 59 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.47822195 |
| 60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47716662 |
| 61 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.45927488 |
| 62 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.45903465 |
| 63 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.44844932 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44067125 |
| 65 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.43527623 |
| 66 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.43047088 |
| 67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41734488 |
| 68 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.41695340 |
| 69 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.40715016 |
| 70 | P300_27268052_Chip-Seq_Bcells_Human | 1.40117456 |
| 71 | MAF_26560356_Chip-Seq_TH1_Human | 1.39728575 |
| 72 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.38716680 |
| 73 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38427427 |
| 74 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.37803949 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37514098 |
| 76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.37185833 |
| 77 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.36970946 |
| 78 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36567168 |
| 79 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35574196 |
| 80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35274735 |
| 81 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35042329 |
| 82 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34855431 |
| 83 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.32359762 |
| 84 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30429783 |
| 85 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.30266261 |
| 86 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29514383 |
| 87 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.29277514 |
| 88 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28704860 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.27195522 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26634168 |
| 91 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.26255499 |
| 92 | MYC_22102868_ChIP-Seq_BL_Human | 1.26060432 |
| 93 | ERA_21632823_ChIP-Seq_H3396_Human | 1.25753962 |
| 94 | SA1_27219007_Chip-Seq_Bcells_Human | 1.24520012 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23987888 |
| 96 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.23055033 |
| 97 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.22488975 |
| 98 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.22411573 |
| 99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22095975 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21691882 |
| 101 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.21416000 |
| 102 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20973945 |
| 103 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20770578 |
| 104 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20729318 |
| 105 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19438615 |
| 106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18708961 |
| 107 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.17772904 |
| 108 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.16032158 |
| 109 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16029811 |
| 110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15294568 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15071720 |
| 112 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.14003261 |
| 113 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13553020 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13521302 |
| 115 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.13369831 |
| 116 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.12923792 |
| 117 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12042220 |
| 118 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11645047 |
| 119 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.10752223 |
| 120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09947667 |
| 121 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.09805531 |
| 122 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08989364 |
| 123 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08985843 |
| 124 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.08086820 |
| 125 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07771686 |
| 126 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.07548707 |
| 127 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.06850951 |
| 128 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06317962 |
| 129 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05309431 |
| 130 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.04481305 |
| 131 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04170971 |
| 132 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04004881 |
| 133 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.02593620 |
| 134 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.01812469 |
| 135 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01663780 |
| 136 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.00804380 |
| 137 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.99547929 |
| 138 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.99154429 |
| 139 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97402234 |
| 140 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.97273320 |
| 141 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.96493323 |
| 142 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.96493323 |
| 143 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.96493323 |
| 144 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.96221568 |
| 145 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95336482 |
| 146 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94789633 |
| 147 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94775041 |
| 148 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.93813986 |
| 149 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.91011028 |
| 150 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.90474222 |
| 151 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90152584 |
| 152 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88705567 |
| 153 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.88003508 |
| 154 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.87664898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.42700915 |
| 2 | MP0005083_abnormal_biliary_tract | 4.02916853 |
| 3 | MP0001666_abnormal_nutrient_absorption | 3.95838492 |
| 4 | MP0005365_abnormal_bile_salt | 3.71056780 |
| 5 | MP0003693_abnormal_embryo_hatching | 3.27507858 |
| 6 | MP0003186_abnormal_redox_activity | 3.14205816 |
| 7 | MP0005451_abnormal_body_composition | 2.83162201 |
| 8 | MP0009840_abnormal_foam_cell | 2.82628323 |
| 9 | MP0005220_abnormal_exocrine_pancreas | 2.68437252 |
| 10 | MP0003436_decreased_susceptibility_to | 2.66288263 |
| 11 | MP0005671_abnormal_response_to | 2.61637633 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.51399460 |
| 13 | MP0006036_abnormal_mitochondrial_physio | 2.49723016 |
| 14 | MP0005332_abnormal_amino_acid | 2.47806658 |
| 15 | MP0005084_abnormal_gallbladder_morpholo | 2.45475949 |
| 16 | MP0003656_abnormal_erythrocyte_physiolo | 2.44428971 |
| 17 | MP0000685_abnormal_immune_system | 2.43760829 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.29419447 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.25824498 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 2.21900357 |
| 21 | MP0005387_immune_system_phenotype | 2.19768149 |
| 22 | MP0001790_abnormal_immune_system | 2.19768149 |
| 23 | MP0001800_abnormal_humoral_immune | 2.18230911 |
| 24 | MP0005025_abnormal_response_to | 2.12408081 |
| 25 | MP0004957_abnormal_blastocyst_morpholog | 2.08702834 |
| 26 | MP0000372_irregular_coat_pigmentation | 2.08688501 |
| 27 | MP0002723_abnormal_immune_serum | 2.05690119 |
| 28 | MP0009785_altered_susceptibility_to | 2.01885317 |
| 29 | MP0001764_abnormal_homeostasis | 2.00135845 |
| 30 | MP0002139_abnormal_hepatobiliary_system | 1.99215047 |
| 31 | MP0000749_muscle_degeneration | 1.97356817 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.95551507 |
| 33 | MP0004147_increased_porphyrin_level | 1.88386493 |
| 34 | MP0000015_abnormal_ear_pigmentation | 1.85919885 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.85393602 |
| 36 | MP0001819_abnormal_immune_cell | 1.84473129 |
| 37 | MP0002452_abnormal_antigen_presenting | 1.83798635 |
| 38 | MP0006035_abnormal_mitochondrial_morpho | 1.77627435 |
| 39 | MP0005330_cardiomyopathy | 1.76465492 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.75559097 |
| 41 | MP0004084_abnormal_cardiac_muscle | 1.74268942 |
| 42 | MP0000750_abnormal_muscle_regeneration | 1.72674893 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.69110697 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.62526339 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.61038958 |
| 46 | MP0002419_abnormal_innate_immunity | 1.59874106 |
| 47 | MP0008875_abnormal_xenobiotic_pharmacok | 1.59493569 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.57255806 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.48279534 |
| 50 | MP0003718_maternal_effect | 1.47107761 |
| 51 | MP0005360_urolithiasis | 1.45536139 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.44437504 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.44101678 |
| 54 | MP0000716_abnormal_immune_system | 1.43374048 |
| 55 | MP0002269_muscular_atrophy | 1.40506751 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.40469575 |
| 57 | MP0002163_abnormal_gland_morphology | 1.37585655 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.37102595 |
| 59 | MP0005319_abnormal_enzyme/_coenzyme | 1.36803916 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.36800315 |
| 61 | MP0004381_abnormal_hair_follicle | 1.32701453 |
| 62 | MP0003195_calcinosis | 1.30377783 |
| 63 | MP0000358_abnormal_cell_content/ | 1.29583483 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.28592403 |
| 65 | MP0000678_abnormal_parathyroid_gland | 1.28584139 |
| 66 | MP0002398_abnormal_bone_marrow | 1.27141161 |
| 67 | MP0009278_abnormal_bone_marrow | 1.26617595 |
| 68 | MP0004036_abnormal_muscle_relaxation | 1.26412910 |
| 69 | MP0002405_respiratory_system_inflammati | 1.24669404 |
| 70 | MP0003011_delayed_dark_adaptation | 1.23842167 |
| 71 | MP0002429_abnormal_blood_cell | 1.23730479 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.21545787 |
| 73 | MP0002132_abnormal_respiratory_system | 1.21287988 |
| 74 | MP0005410_abnormal_fertilization | 1.20513007 |
| 75 | MP0001756_abnormal_urination | 1.20000555 |
| 76 | MP0002722_abnormal_immune_system | 1.19183454 |
| 77 | MP0001968_abnormal_touch/_nociception | 1.18569298 |
| 78 | MP0001905_abnormal_dopamine_level | 1.17699899 |
| 79 | MP0009764_decreased_sensitivity_to | 1.16791677 |
| 80 | MP0003724_increased_susceptibility_to | 1.15986925 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 1.14839439 |
| 82 | MP0005408_hypopigmentation | 1.13608270 |
| 83 | MP0004215_abnormal_myocardial_fiber | 1.12879449 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 1.12041524 |
| 85 | MP0000747_muscle_weakness | 1.08196348 |
| 86 | MP0001663_abnormal_digestive_system | 1.07292652 |
| 87 | MP0003303_peritoneal_inflammation | 1.06859262 |
| 88 | MP0004043_abnormal_pH_regulation | 1.06595992 |
| 89 | MP0003868_abnormal_feces_composition | 1.04424277 |
| 90 | MP0003111_abnormal_nucleus_morphology | 1.02942477 |
| 91 | MP0002933_joint_inflammation | 1.02176288 |
| 92 | MP0006082_CNS_inflammation | 1.01722406 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 1.00064639 |
| 94 | MP0008438_abnormal_cutaneous_collagen | 0.99952772 |
| 95 | MP0008260_abnormal_autophagy | 0.98643345 |
| 96 | MP0000598_abnormal_liver_morphology | 0.98439777 |
| 97 | MP0000538_abnormal_urinary_bladder | 0.97825629 |
| 98 | MP0008872_abnormal_physiological_respon | 0.97493459 |
| 99 | MP0003941_abnormal_skin_development | 0.97409873 |
| 100 | MP0003077_abnormal_cell_cycle | 0.97173449 |
| 101 | MP0002396_abnormal_hematopoietic_system | 0.96518012 |
| 102 | MP0000609_abnormal_liver_physiology | 0.96273417 |
| 103 | MP0001533_abnormal_skeleton_physiology | 0.95769559 |
| 104 | MP0002736_abnormal_nociception_after | 0.95412593 |
| 105 | MP0000703_abnormal_thymus_morphology | 0.95144592 |
| 106 | MP0005165_increased_susceptibility_to | 0.95076794 |
| 107 | MP0001664_abnormal_digestion | 0.94567534 |
| 108 | MP0005367_renal/urinary_system_phenotyp | 0.91500498 |
| 109 | MP0000516_abnormal_urinary_system | 0.91500498 |
| 110 | MP0002972_abnormal_cardiac_muscle | 0.91233938 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.91078310 |
| 112 | MP0008469_abnormal_protein_level | 0.90920694 |
| 113 | MP0003646_muscle_fatigue | 0.90481421 |
| 114 | MP0000490_abnormal_crypts_of | 0.90048983 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.87926378 |
| 116 | MP0010094_abnormal_chromosome_stability | 0.86974996 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.85904638 |
| 118 | MP0003075_altered_response_to | 0.84746565 |
| 119 | MP0004264_abnormal_extraembryonic_tissu | 0.83986067 |
| 120 | MP0008932_abnormal_embryonic_tissue | 0.83707265 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82950420 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.81742890 |
| 123 | MP0005376_homeostasis/metabolism_phenot | 0.81493410 |
| 124 | MP0005266_abnormal_metabolism | 0.81449173 |
| 125 | MP0010329_abnormal_lipoprotein_level | 0.81169423 |
| 126 | MP0003137_abnormal_impulse_conducting | 0.80491095 |
| 127 | MP0002693_abnormal_pancreas_physiology | 0.79745900 |
| 128 | MP0004233_abnormal_muscle_weight | 0.79495993 |
| 129 | MP0009384_cardiac_valve_regurgitation | 0.79254793 |
| 130 | MP0004019_abnormal_vitamin_homeostasis | 0.78584571 |
| 131 | MP0003866_abnormal_defecation | 0.78506881 |
| 132 | MP0003878_abnormal_ear_physiology | 0.77458286 |
| 133 | MP0005377_hearing/vestibular/ear_phenot | 0.77458286 |
| 134 | MP0000343_altered_response_to | 0.77162538 |
| 135 | MP0005166_decreased_susceptibility_to | 0.76773388 |
| 136 | MP0002136_abnormal_kidney_physiology | 0.76630007 |
| 137 | MP0000858_altered_metastatic_potential | 0.76233950 |
| 138 | MP0002019_abnormal_tumor_incidence | 0.75506945 |
| 139 | MP0002095_abnormal_skin_pigmentation | 0.75166680 |
| 140 | MP0001986_abnormal_taste_sensitivity | 0.75143709 |
| 141 | MP0005670_abnormal_white_adipose | 0.72447845 |
| 142 | MP0001853_heart_inflammation | 0.70875222 |
| 143 | MP0005023_abnormal_wound_healing | 0.69879306 |
| 144 | MP0008058_abnormal_DNA_repair | 0.69701453 |
| 145 | MP0001544_abnormal_cardiovascular_syste | 0.68810794 |
| 146 | MP0005385_cardiovascular_system_phenoty | 0.68810794 |
| 147 | MP0005075_abnormal_melanosome_morpholog | 0.67723561 |
| 148 | MP0010630_abnormal_cardiac_muscle | 0.67120925 |
| 149 | MP0003950_abnormal_plasma_membrane | 0.65984475 |
| 150 | MP0006054_spinal_hemorrhage | 0.65963256 |
| 151 | MP0004087_abnormal_muscle_fiber | 0.65867979 |
| 152 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65813224 |
| 153 | MP0003786_premature_aging | 0.65117832 |
| 154 | MP0009765_abnormal_xenobiotic_induced | 0.64368576 |
| 155 | MP0001845_abnormal_inflammatory_respons | 0.63863379 |
| 156 | MP0008775_abnormal_heart_ventricle | 0.62494165 |
| 157 | MP0005310_abnormal_salivary_gland | 0.61948387 |
| 158 | MP0001661_extended_life_span | 0.61432714 |
| 159 | MP0003123_paternal_imprinting | 0.60852606 |
| 160 | MP0003828_pulmonary_edema | 0.60499249 |
| 161 | MP0003959_abnormal_lean_body | 0.59410989 |
| 162 | MP0001873_stomach_inflammation | 0.58343499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatic necrosis (HP:0002605) | 4.44227680 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.21312462 |
| 3 | Hepatocellular necrosis (HP:0001404) | 4.11704646 |
| 4 | Mitochondrial inheritance (HP:0001427) | 4.02463683 |
| 5 | Acute encephalopathy (HP:0006846) | 4.02391552 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.94498736 |
| 7 | Increased CSF lactate (HP:0002490) | 3.75036941 |
| 8 | Hyperglycinuria (HP:0003108) | 3.73786172 |
| 9 | Dicarboxylic aciduria (HP:0003215) | 3.53363174 |
| 10 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.53363174 |
| 11 | Hypoglycemic coma (HP:0001325) | 3.46858852 |
| 12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.44619050 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 3.44619050 |
| 14 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.43083290 |
| 15 | Carpal bone hypoplasia (HP:0001498) | 3.39142086 |
| 16 | Hyperglycinemia (HP:0002154) | 3.34088329 |
| 17 | Cerebral edema (HP:0002181) | 3.32580260 |
| 18 | Generalized aminoaciduria (HP:0002909) | 3.32190016 |
| 19 | Abnormal number of erythroid precursors (HP:0012131) | 3.29633059 |
| 20 | Cerebral hypomyelination (HP:0006808) | 3.22974185 |
| 21 | Progressive macrocephaly (HP:0004481) | 3.20265085 |
| 22 | Lactic acidosis (HP:0003128) | 3.20133506 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.15352329 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.13513332 |
| 25 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.12945213 |
| 26 | Multiple enchondromatosis (HP:0005701) | 3.10171480 |
| 27 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.07393132 |
| 28 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.07393132 |
| 29 | Lethargy (HP:0001254) | 2.93688363 |
| 30 | Methylmalonic aciduria (HP:0012120) | 2.91313848 |
| 31 | Respiratory failure (HP:0002878) | 2.89723353 |
| 32 | Increased serum pyruvate (HP:0003542) | 2.89485037 |
| 33 | Abnormality of glycolysis (HP:0004366) | 2.89485037 |
| 34 | Increased serum lactate (HP:0002151) | 2.88229620 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.87345818 |
| 36 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.72128288 |
| 37 | CNS demyelination (HP:0007305) | 2.68610576 |
| 38 | Nausea (HP:0002018) | 2.68221219 |
| 39 | Ketosis (HP:0001946) | 2.67023187 |
| 40 | Progressive muscle weakness (HP:0003323) | 2.64436890 |
| 41 | Exercise intolerance (HP:0003546) | 2.63626508 |
| 42 | Steatorrhea (HP:0002570) | 2.63425857 |
| 43 | 3-Methylglutaconic aciduria (HP:0003535) | 2.61026342 |
| 44 | Ketoacidosis (HP:0001993) | 2.59866765 |
| 45 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.59104208 |
| 46 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.56326637 |
| 47 | Abnormality of alanine metabolism (HP:0010916) | 2.56326637 |
| 48 | Hyperalaninemia (HP:0003348) | 2.56326637 |
| 49 | Ileus (HP:0002595) | 2.55485332 |
| 50 | Increased muscle lipid content (HP:0009058) | 2.54426919 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 2.50691312 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.50419026 |
| 53 | Obstructive lung disease (HP:0006536) | 2.50419026 |
| 54 | Hyperammonemia (HP:0001987) | 2.47778952 |
| 55 | Exertional dyspnea (HP:0002875) | 2.45503500 |
| 56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.45491066 |
| 57 | Proximal tubulopathy (HP:0000114) | 2.45404638 |
| 58 | Panhypogammaglobulinemia (HP:0003139) | 2.44917717 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.44036007 |
| 60 | Cerebral palsy (HP:0100021) | 2.43967609 |
| 61 | Lipid accumulation in hepatocytes (HP:0006561) | 2.41100959 |
| 62 | Gout (HP:0001997) | 2.40073901 |
| 63 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.39637290 |
| 64 | Increased intramyocellular lipid droplets (HP:0012240) | 2.35442210 |
| 65 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.34186491 |
| 66 | Agammaglobulinemia (HP:0004432) | 2.33782517 |
| 67 | Abnormality of serum amino acid levels (HP:0003112) | 2.32653830 |
| 68 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.29083014 |
| 69 | Macrocytic anemia (HP:0001972) | 2.28587824 |
| 70 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.28075584 |
| 71 | Degeneration of anterior horn cells (HP:0002398) | 2.26262362 |
| 72 | Abnormality of the anterior horn cell (HP:0006802) | 2.26262362 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 2.25640769 |
| 74 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.25640769 |
| 75 | Hypoplasia of the pons (HP:0012110) | 2.24922484 |
| 76 | Renal Fanconi syndrome (HP:0001994) | 2.23722104 |
| 77 | Diaphragmatic weakness (HP:0009113) | 2.23011107 |
| 78 | Emotional lability (HP:0000712) | 2.22897407 |
| 79 | Hypertensive crisis (HP:0100735) | 2.22798402 |
| 80 | Recurrent bacterial skin infections (HP:0005406) | 2.22298834 |
| 81 | Fat malabsorption (HP:0002630) | 2.21986250 |
| 82 | Prolonged neonatal jaundice (HP:0006579) | 2.19319967 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.18930792 |
| 84 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.17039096 |
| 85 | Respiratory difficulties (HP:0002880) | 2.16932629 |
| 86 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.14559748 |
| 87 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.14559748 |
| 88 | Abnormality of glycolipid metabolism (HP:0010969) | 2.14559748 |
| 89 | Stomatitis (HP:0010280) | 2.14391231 |
| 90 | Ventricular tachycardia (HP:0004756) | 2.14373335 |
| 91 | Severe visual impairment (HP:0001141) | 2.14233338 |
| 92 | Pustule (HP:0200039) | 2.13697004 |
| 93 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13226818 |
| 94 | Type I transferrin isoform profile (HP:0003642) | 2.12253354 |
| 95 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.11853724 |
| 96 | Vomiting (HP:0002013) | 2.11068211 |
| 97 | Progressive microcephaly (HP:0000253) | 2.10379675 |
| 98 | Reduced antithrombin III activity (HP:0001976) | 2.10321010 |
| 99 | Recurrent abscess formation (HP:0002722) | 2.10319036 |
| 100 | Hypoglycemic seizures (HP:0002173) | 2.09867832 |
| 101 | Abnormal protein glycosylation (HP:0012346) | 2.08710241 |
| 102 | Abnormal glycosylation (HP:0012345) | 2.08710241 |
| 103 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.08710241 |
| 104 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.08710241 |
| 105 | Abnormality of the pons (HP:0007361) | 2.08329102 |
| 106 | Testicular atrophy (HP:0000029) | 2.08144404 |
| 107 | Myoglobinuria (HP:0002913) | 2.07327206 |
| 108 | Glycosuria (HP:0003076) | 2.06497280 |
| 109 | Abnormality of urine glucose concentration (HP:0011016) | 2.06497280 |
| 110 | Increased IgM level (HP:0003496) | 2.04734362 |
| 111 | Breast hypoplasia (HP:0003187) | 2.02554146 |
| 112 | Increased hepatocellular lipid droplets (HP:0006565) | 2.01636532 |
| 113 | Rhabdomyolysis (HP:0003201) | 2.01465697 |
| 114 | Opisthotonus (HP:0002179) | 2.00059411 |
| 115 | Metabolic acidosis (HP:0001942) | 1.99120259 |
| 116 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.98252307 |
| 117 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97442106 |
| 118 | Optic disc pallor (HP:0000543) | 1.96631806 |
| 119 | Microretrognathia (HP:0000308) | 1.96357669 |
| 120 | Congenital, generalized hypertrichosis (HP:0004540) | 1.95667020 |
| 121 | Petechiae (HP:0000967) | 1.95234360 |
| 122 | Leukodystrophy (HP:0002415) | 1.94444201 |
| 123 | Poor head control (HP:0002421) | 1.94241245 |
| 124 | Bulbar palsy (HP:0001283) | 1.94182290 |
| 125 | Aplastic anemia (HP:0001915) | 1.92425862 |
| 126 | Ragged-red muscle fibers (HP:0003200) | 1.92040382 |
| 127 | CNS hypomyelination (HP:0003429) | 1.91186208 |
| 128 | Abnormality of renal resorption (HP:0011038) | 1.90978662 |
| 129 | Birth length less than 3rd percentile (HP:0003561) | 1.90297116 |
| 130 | Delayed CNS myelination (HP:0002188) | 1.89917555 |
| 131 | Spastic paraparesis (HP:0002313) | 1.89883479 |
| 132 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.89422269 |
| 133 | Palpitations (HP:0001962) | 1.88213577 |
| 134 | Unsteady gait (HP:0002317) | 1.88103615 |
| 135 | Meningitis (HP:0001287) | 1.87865266 |
| 136 | Muscle fiber splitting (HP:0003555) | 1.86699087 |
| 137 | Granulocytopenia (HP:0001913) | 1.86496860 |
| 138 | Absent/shortened dynein arms (HP:0200106) | 1.84957604 |
| 139 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.84957604 |
| 140 | Mesangial abnormality (HP:0001966) | 1.84467028 |
| 141 | Myositis (HP:0100614) | 1.83167286 |
| 142 | Abnormality of T cells (HP:0002843) | 1.82443042 |
| 143 | Recurrent skin infections (HP:0001581) | 1.82239835 |
| 144 | Increased serum ferritin (HP:0003281) | 1.78983265 |
| 145 | Neutropenia (HP:0001875) | 1.75550784 |
| 146 | Prostate neoplasm (HP:0100787) | 1.72332258 |
| 147 | IgG deficiency (HP:0004315) | 1.72084763 |
| 148 | Dysostosis multiplex (HP:0000943) | 1.71233861 |
| 149 | Muscle fiber atrophy (HP:0100295) | 1.71061050 |
| 150 | Myopathic facies (HP:0002058) | 1.69645571 |
| 151 | Hyperthyroidism (HP:0000836) | 1.68986875 |
| 152 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.66781136 |
| 153 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.66781136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.90482684 |
| 2 | VRK2 | 4.79345305 |
| 3 | NME2 | 4.52666489 |
| 4 | BUB1 | 3.18452027 |
| 5 | MAP4K1 | 2.98175250 |
| 6 | EIF2AK3 | 2.72885286 |
| 7 | WEE1 | 2.67358023 |
| 8 | ERN1 | 2.64941509 |
| 9 | STK16 | 2.61325641 |
| 10 | EIF2AK1 | 2.46779687 |
| 11 | MYLK | 2.36535134 |
| 12 | SMG1 | 2.29306911 |
| 13 | MAPKAPK3 | 2.25023495 |
| 14 | TESK2 | 2.15827689 |
| 15 | IRAK3 | 2.10580778 |
| 16 | PRKD3 | 2.03717348 |
| 17 | AKT3 | 1.90060152 |
| 18 | TNK2 | 1.89431345 |
| 19 | PIM2 | 1.89415046 |
| 20 | MAP2K2 | 1.88113281 |
| 21 | INSRR | 1.82511592 |
| 22 | MST4 | 1.71422149 |
| 23 | KDR | 1.71212285 |
| 24 | EPHA2 | 1.69972659 |
| 25 | RPS6KB2 | 1.68045699 |
| 26 | NUAK1 | 1.58299207 |
| 27 | BRSK2 | 1.57551069 |
| 28 | GRK6 | 1.57168358 |
| 29 | TSSK6 | 1.52221613 |
| 30 | PINK1 | 1.50315691 |
| 31 | FLT3 | 1.47635059 |
| 32 | MAP4K2 | 1.43085784 |
| 33 | BRAF | 1.36910189 |
| 34 | NME1 | 1.34757697 |
| 35 | TAOK3 | 1.34563466 |
| 36 | STK38L | 1.31369867 |
| 37 | PRKD2 | 1.29724542 |
| 38 | TXK | 1.28809648 |
| 39 | TYK2 | 1.25150184 |
| 40 | TAF1 | 1.24116435 |
| 41 | ZAK | 1.20922118 |
| 42 | ARAF | 1.17754760 |
| 43 | CSNK1G3 | 1.15399186 |
| 44 | SCYL2 | 1.11695631 |
| 45 | TESK1 | 1.11649326 |
| 46 | TTN | 1.10629916 |
| 47 | VRK1 | 1.10435336 |
| 48 | FRK | 1.07157674 |
| 49 | ZAP70 | 1.05905848 |
| 50 | MAP2K3 | 1.05020596 |
| 51 | PIK3CG | 1.04735209 |
| 52 | LRRK2 | 1.04203810 |
| 53 | TRIB3 | 1.03855952 |
| 54 | DAPK1 | 1.01027209 |
| 55 | ADRBK2 | 1.00932014 |
| 56 | RIPK4 | 1.00107615 |
| 57 | PDK2 | 0.96884817 |
| 58 | CCNB1 | 0.95967756 |
| 59 | MAP3K8 | 0.95843361 |
| 60 | BTK | 0.95254811 |
| 61 | ILK | 0.94136952 |
| 62 | LIMK1 | 0.92623881 |
| 63 | PIK3CA | 0.91000982 |
| 64 | MARK3 | 0.89222599 |
| 65 | EEF2K | 0.87127129 |
| 66 | OBSCN | 0.85208828 |
| 67 | SYK | 0.85199993 |
| 68 | TRPM7 | 0.83218526 |
| 69 | MAP3K11 | 0.81523361 |
| 70 | RPS6KA4 | 0.81065633 |
| 71 | CSNK1A1L | 0.81055101 |
| 72 | MAPK11 | 0.79635446 |
| 73 | IRAK2 | 0.79413744 |
| 74 | AURKA | 0.78308714 |
| 75 | TLK1 | 0.73822575 |
| 76 | MAP2K6 | 0.73114706 |
| 77 | SRPK1 | 0.73010119 |
| 78 | KIT | 0.72947306 |
| 79 | GRK1 | 0.72747501 |
| 80 | NEK1 | 0.71872606 |
| 81 | IRAK4 | 0.71806496 |
| 82 | MAP3K5 | 0.70623917 |
| 83 | PRKCQ | 0.68195177 |
| 84 | TAOK1 | 0.67233837 |
| 85 | MAPK12 | 0.66999538 |
| 86 | LYN | 0.65465253 |
| 87 | FES | 0.65356592 |
| 88 | HIPK2 | 0.64553639 |
| 89 | STK10 | 0.63613826 |
| 90 | MATK | 0.63519642 |
| 91 | PRKCI | 0.63098589 |
| 92 | CDK19 | 0.62581802 |
| 93 | CSNK1G1 | 0.62561316 |
| 94 | PLK1 | 0.60951898 |
| 95 | TBK1 | 0.60797233 |
| 96 | TEC | 0.60525951 |
| 97 | PKN2 | 0.60005789 |
| 98 | AURKB | 0.59955912 |
| 99 | CSNK1G2 | 0.59807168 |
| 100 | BRSK1 | 0.59399151 |
| 101 | MAPKAPK5 | 0.56994335 |
| 102 | GRK5 | 0.56662772 |
| 103 | DAPK3 | 0.56537991 |
| 104 | PHKG2 | 0.55709472 |
| 105 | PHKG1 | 0.55709472 |
| 106 | TAOK2 | 0.54873934 |
| 107 | BLK | 0.53502906 |
| 108 | PAK2 | 0.52369311 |
| 109 | PASK | 0.51611455 |
| 110 | MAPKAPK2 | 0.50615819 |
| 111 | MAP3K3 | 0.47718649 |
| 112 | PAK1 | 0.47415608 |
| 113 | PAK4 | 0.46856860 |
| 114 | MAP2K1 | 0.45855009 |
| 115 | LCK | 0.43484260 |
| 116 | PDPK1 | 0.43417865 |
| 117 | WNK4 | 0.43094554 |
| 118 | CSNK2A1 | 0.42942604 |
| 119 | SIK2 | 0.42931957 |
| 120 | IKBKB | 0.40880175 |
| 121 | NEK9 | 0.40769321 |
| 122 | CSNK2A2 | 0.40110244 |
| 123 | PLK4 | 0.39977274 |
| 124 | ADRBK1 | 0.39752841 |
| 125 | ITK | 0.39686495 |
| 126 | RPS6KA2 | 0.39463404 |
| 127 | LMTK2 | 0.38576364 |
| 128 | STK24 | 0.37880554 |
| 129 | PTK2B | 0.37722121 |
| 130 | MAP3K1 | 0.37432613 |
| 131 | IKBKE | 0.36487334 |
| 132 | EIF2AK2 | 0.35933991 |
| 133 | ROCK2 | 0.35034718 |
| 134 | CDK7 | 0.34380573 |
| 135 | TTK | 0.34337865 |
| 136 | DYRK2 | 0.34171174 |
| 137 | STK39 | 0.32686779 |
| 138 | PBK | 0.32358703 |
| 139 | EPHB1 | 0.32225652 |
| 140 | ABL2 | 0.31321369 |
| 141 | RPS6KA5 | 0.31137440 |
| 142 | JAK3 | 0.30393694 |
| 143 | PLK3 | 0.29497492 |
| 144 | RPS6KA6 | 0.27580636 |
| 145 | MUSK | 0.27097534 |
| 146 | SIK1 | 0.26158247 |
| 147 | RPS6KL1 | 0.25293355 |
| 148 | RPS6KC1 | 0.25293355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.36283834 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.29222594 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.09044998 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.68655333 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.67876296 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.51765352 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.46498388 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.30914781 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.13442771 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09356045 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.08600127 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.07837654 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.03823898 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.96894188 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.85051637 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.84732655 |
| 17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.83965563 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.79931497 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.79709191 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.77602449 |
| 21 | DNA replication_Homo sapiens_hsa03030 | 1.77542714 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73982283 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69349318 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.66657643 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.66476407 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.65359920 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.59212508 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.58165530 |
| 29 | Mismatch repair_Homo sapiens_hsa03430 | 1.56719419 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.55854854 |
| 31 | Alzheimers disease_Homo sapiens_hsa05010 | 1.50494505 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.48368921 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.48318215 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.47341390 |
| 35 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.46021128 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.45089997 |
| 37 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.44938841 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.44576267 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41734272 |
| 40 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.40587313 |
| 41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.40567399 |
| 42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.38956243 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31938288 |
| 44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.30852006 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.30433750 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.30231669 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25305600 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.23475576 |
| 49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.23262582 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.19774415 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 1.19595989 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.17261633 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17048886 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16663508 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15403778 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12657906 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12257212 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.11135872 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.08212763 |
| 60 | Base excision repair_Homo sapiens_hsa03410 | 1.07584186 |
| 61 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.06886380 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.01729132 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00708215 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99270521 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97026645 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.96920749 |
| 67 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96133938 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.95711697 |
| 69 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.95345941 |
| 70 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95049964 |
| 71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.94166201 |
| 72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93937552 |
| 73 | RNA transport_Homo sapiens_hsa03013 | 0.93626800 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92789280 |
| 75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92241404 |
| 76 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.92028869 |
| 77 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.89086288 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88548543 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87530961 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86056565 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85666520 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84754464 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84188186 |
| 84 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83980565 |
| 85 | Homologous recombination_Homo sapiens_hsa03440 | 0.82296555 |
| 86 | Spliceosome_Homo sapiens_hsa03040 | 0.81776949 |
| 87 | Purine metabolism_Homo sapiens_hsa00230 | 0.81422450 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.80262407 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80156865 |
| 90 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79654722 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.79489454 |
| 92 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.79130097 |
| 93 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78989594 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78799231 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78781555 |
| 96 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77504473 |
| 97 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.76881865 |
| 98 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.74568554 |
| 99 | Leishmaniasis_Homo sapiens_hsa05140 | 0.73842293 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.70439249 |
| 101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69964881 |
| 102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69126459 |
| 103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65986786 |
| 104 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65927658 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65435414 |
| 106 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64193089 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63070421 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61979088 |
| 109 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58873029 |
| 110 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58729416 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57599293 |
| 112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56438434 |
| 113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54097003 |
| 114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53486331 |
| 115 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52898205 |
| 116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52775304 |
| 117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52221718 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.51743635 |
| 119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47647481 |
| 120 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47319815 |
| 121 | Lysosome_Homo sapiens_hsa04142 | 0.45552674 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45441616 |
| 123 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.44338967 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41797799 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41733086 |
| 126 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.39129836 |
| 127 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36544724 |
| 128 | Retinol metabolism_Homo sapiens_hsa00830 | 0.34256897 |
| 129 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.32526823 |
| 130 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32244927 |
| 131 | Measles_Homo sapiens_hsa05162 | 0.32122724 |
| 132 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32099749 |
| 133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31128490 |
| 134 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30960902 |
| 135 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30850354 |
| 136 | Phagosome_Homo sapiens_hsa04145 | 0.30324117 |

